KP Tissue (TSE:KPT – Get Free Report) posted its earnings results on Thursday. The company reported C$0.22 earnings per share (EPS) for the quarter, reports.
Here are the key takeaways from KP Tissue’s conference call:
- KP Tissue reported Q1 2026 adjusted EBITDA of CAD 86.9 million, up 14.6% year over year, with margin improving to 16.0% from 13.9% on the back of lower pulp and warehousing costs.
- Revenue was essentially flat at CAD 544.6 million, as modest growth in Canada was offset by a decline in U.S. sales and unfavorable foreign exchange.
- The company said its operations outperformed targets across all sites, and the new Memphis converting line ramped as planned in early Q2 to add capacity to the U.S. network.
- Management reiterated plans for a new western U.S. TAD tissue plant, targeting an official announcement by the end of the first half of 2026 and startup in late 2028.
- Executives flagged rising fuel, freight and other input costs as a key watch item, saying they will consider pricing actions if needed, while Q2 adjusted EBITDA is expected to be in line with Q1.
KP Tissue Stock Up 2.7%
Shares of TSE KPT traded up C$0.31 during midday trading on Friday, hitting C$11.90. The stock had a trading volume of 17,054 shares, compared to its average volume of 13,739. The stock has a 50 day simple moving average of C$11.10 and a 200-day simple moving average of C$10.51. The company has a market capitalization of C$119.18 million, a PE ratio of 14.00, a P/E/G ratio of -0.88 and a beta of 0.47. KP Tissue has a 1 year low of C$8.66 and a 1 year high of C$11.95.
Analyst Ratings Changes
View Our Latest Analysis on KP Tissue
About KP Tissue
KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems.
Read More
- Five stocks we like better than KP Tissue
- 3 AI Data Center Stocks Worth Watching for Capital Rotation
- McDonald’s Is the Cheapest It’s Been in Years—Does That Make It a Buy?
- Karman: Defense Darling’s Outlook Strengthens After 40% Drop
- Aeluma’s Post-Earnings Dip Creates a Buying Opportunity
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
